KATRINA KORRECKT: Open Payments
NPI 1124503974 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$589 in 14 payments from 8 companies in 2025. Trend: 2023 $203 · 2024 $208 · 2025 $589
Food & beverage: $589
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $209 |
| Edwards Lifesciences Corporation | 2 | $150 |
| PFIZER INC. | 3 | $84 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| BridgeBio Pharma, Inc. | 1 | $35 |
| Novo Nordisk Inc | 1 | $34 |
| ABIOMED | 1 | $28 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $13 |
Products named: TRICLIP, ELIQUIS, MITRACLIP, Attruby, Wegovy, FARXIGA, LifeVest, EVOQUE.
Industry payments across WA — which companies pay providers there.
